Please clarify, how they have wasted shareholders money?
By positioning Tapimmune, in the immensely competitive field of Immunology as a viable participant, by structuring the company to date too succeed [if data is positive]
You have not offended me in any way, I have no gripe with the company or Glynn for that matter.
I also hate to lose money, therefore my indulgence in substantial DD on all my investments, TPIV no exception.
How do you make statements/predictions, that they have wasted shareholders money, when they have positioned themselves to be successful. If they had spent all this time and money and still had no viable product, than I may agree upon your reasoning.
Do you think that completing the manufacturing process, was either easy or without cost, do you think that acquiring the licencing for multiple vaccine candidates from Mayo, was fruitless and costless?
Do some DD and get actual costs as to what it takes to bring a drug to market, the costs, and timelines then see if Tapimmune falls within those guidelines.
I think you may be surprised.
Clarify what commitments TPIV has made, and which ones that they have not delivered on?
Throughout the years, TPIV has made certain statements, of which many if not all have been accomplished, their technology is new, unique, and possibly game changing, thus the fact that they have had a hard time to make believers of many, especially big BP.
Give me examples of statements made that they have not executed? And I will give you my rebuttal.
Really "numerous" commitments, no execution.
Tapimmune never had $150 million, and squandered it! Any monies have been through series of financings over more than a decade, that kept the company afloat.
Same as any other Bio, the difference here is that Tapimmune, now has a viable product, where as, many have spent mill/bill's and in the end still found out their technologies were mute in the end.
Glynn cannot will the science to succeed, you do a great disservice to him and his late wife.
How could one possibly bring a lawsuit, against a company that has accomplished as much as Tapimmune, and sits in such a enviable position, if the science holds true in Phase 11's.
Lawsuits may only be brought if there has been an outright plan to deceive shareholders, how would any lawyer contend that TPIV and Glynn have not been forthcoming with any and all news to date.
It is laughable that you think that Tapimmune, is worthy of a lawsuit...timelines to execution are no basis for suits. Loss of investment monies are no basis for suits, when a company has been as transparent as tapimmune.
After all it is not as though, the stock went to 30/50 on pumping , then crashed to our price now, we are a tiny company, that may hold great promise.
That has done whatever has been needed to, to remain a viable entity.
Instead of berating everyone, you should look at the glass half full, as we may be on the thresh hold of something remarkable...or "NOT".
If you feel their is no hope, get out while you have money left, for if the science holds no merit, than you will indeed be left with nothing.
But it is unlikely you will be able to sue, because the science fails in the end.
I will refrain to make another post in your regard, as I do myself a disservice by even letting this become an issue to debate at this point.
Once again best of luck.
BLU
